Staphylococcus aureus and wounds: A review of tea tree oil as a promising antimicrobial

American Journal of Infection Control

Volumn 32, Issue 7, 2004, Pages 402-408

  Halcón, Linda ^a   Milkus, Kelly ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEA TREE OIL;

ANTIMICROBIAL ACTIVITY; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTACT DERMATITIS; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HEALTH SURVEY; HUMAN; HYPERSENSITIVITY; NONHUMAN; OSTEOMYELITIS; REVIEW; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

EID: 7444227476     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2003.12.008     Document Type: Article

References (112)

1. Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother. 44:(Suppl A):1999;1-9
2. Mulligan M.E., Murray-Leisure K.A., Ribner B.S., et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 94:1993;313-328
3. Gorak E.J., Yamada S.M., Brown J.D. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis. 29:1999;797-800
4. Blok H.E., Vriens M.R., Weersink A.J., et al. Carriage of methicillin-resistant Staphylococcus aureus (MRSA) after discharge from hospital: follow-up for how long? A Dutch multi-centre study. J Hosp Infect. 48:2001;325-327
5. MacKinnon M.M., Allen K.D. Long-term MRSA carriage in hospital patients. J Hosp Infect. 46:2000;216-221
6. Thomas M.J. Overview of resistance in the 1990's. Chest. 115:1999;3S-8S
7. Theaker C., Ormond-Walshe S., Azadian B., et al. MRSA in the critically ill. J Hosp Infect. 48:2001;98-102
8. Tonge H. Special focus: tissue viability. The management of infected wounds. Nurs Standard. 12:(12):1997;49-53
9. Wright J.B., Lam K., Burrell R.E. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 26:1998;572-577
10. Chan C.H., Loudon K.W. Activity of tea tree oil on methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect. 39:1998;244-245
11. Arnold M.S., Dempsey J.M., Fishman M., et al. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol. 23:2002;69-76
12. Maple P.A., Hamilton-Miller J.M., Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 29:1992;661-668
13. Riley T.V., Carson C.F., Bowman R.A., et al. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust. 161:1994;397-398
14. Irizarry L., Merlin T., Rupp J., et al. Reduced susceptibility of methicillin-resistant Staphylococcus aureus to cetylpyridinium chloride and chlorhexidine. Chemotherapy. 42:1996;248-252
15. May J., Chan C.H., King A., et al. Time-kill studies of tea tree oils on clinical isolates. J Antimicrob Chemother. 45:2000;639-643
16. Hayashi K., Kamiya M., Hayashi T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Planta Med. 61:1995;237-241
17. Larrondo J.V., Agut M., Calvo-Torras M.A. Antimicrobial activity of essences from labiates. Microbios. 82:1995;171-172
18. Tirillini B., Velasquez E.R., Pellegrino R. Chemical composition and antimicrobial activity of essential oil of Piper angustifolium. Planta Med. 62:1996;372-373
19. Mikus J., Harkenthal M., Steverding D., et al. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 66:2000;366-368
20. Gustafson J.E., Liew Y.C., Chew S., et al. Effects of tea tree oil on Escherichia coli. Lett Appl Microbiol. 26:1998;194-198
21. Shapiro S., Meier A., Guggenheim B. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol Immunol. 9:1994;202-208
22. Carson C.F., Riley T.V. Antimicrobial activity of tea tree oil. July 1998;Rural Industries Research and Development Corporation, Nedlands, Western Australia
23. Serkedjieva J., Hay A.J. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antiviral Res. 37:1998;121-130
24. Maudsley F., Kerr K.G. Microbiological safety of essential oils used in complementary therapies and the activity of these compounds against bacterial and fungal pathogens. Support Care Cancer. 7:1999;100-102
25. Carson C.F., Hammer K.A., Riley T.V. Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). Microbios. 82:1995;181-185
26. Harkenthal M., Reichling J., Geiss H.K., et al. Comparative study on the in vitro antibacterial activity of Australian tea tree oil, cajuput oil, niaouli oil, manuka oil, kanuka oil, and eucalyptus oil. Pharmazie. 54:1999;460-463
27. Pattnaik S., Subramanyam V.R., Bapaji M., et al. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios. 89:1997;39-46
28. Peana A.T., Moretti M.D., Juliano C. Chemical composition and antimicrobial action of the essential oils of Salvia desoleana and S. sclarea. Planta Med. 65:1999;752-754
29. Feinblatt H.M. Cajeput-type oil for the treatment of furunculosis. J Natl Med Assoc. 52:1960;32-34
30. Hammer K.A., Carson C.F., Riley T.V. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother. 43:1999;196
31. Walker M. Clinical investigation of Australian Melaleuca Alternifolia oil for a variety of common foot problems. Curr Podiatry. 1972;28-34
32. Hammer K.A., Carson C.F., Riley T.V. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control. 24:1996;186-189
33. Faoagali J., George N., Leditschke J.F. Does tea tree oil have a place in the topical treatment of burns? Burns. 23:1997;349-351
34. Blackwell A.L. Tea tree oil and anaerobic (bacterial) vaginosis. Lancet. 337:1991;300
35. Bassett I.B., Pannowitz D.L., Barnetson R.S. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust. 153:1990;455-458
36. Carson C.F., Cookson B.D., Farrelly H.D., et al. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother. 35:1995;421-424
37. Nelson R.R. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 40:1997;305-306
38. Nelson R.R. Selection of resistance to the essential oil of Melaleuca alternifolia in Staphylococcus aureus. J Antimicrob Chemother. 45:2000;549-550
39. Carson C.F., Riley T.V. The antimicrobial activity of tea tree oil. Med J Aust. 160:1994;236
40. Christoph F., Stahl-Biskup E., Kaulfers P.-M. Death Kinetics of Staphylococcus aureus exposed to commercial tea tree oils s.l. J Essential Oils Res. 13:2001;98-102
41. Saller R., Berger T., Reichling J., et al. Pharmaceutical and medicinal aspects of Australian tea tree oil. Phytomedicine. 5:1998;489-495
42. Satchell A.C., Saurajen A., Bell C., et al. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol. 45:2002;175-178
43. Tong M.M., Altman P.M., Barnetson R.S. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol. 33:1992;145-149
44. Syed T.A., Qureshi Z.A., Ali S.M., et al. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health. 4:1999;284-287
45. Buck D.S., Nidorf D.M., Addino J.G. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract. 38:1994;601-605
46. Satchell A.C., Saurajen A., Bell C., et al. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 47:2002;852-855
47. McCage C.M., Ward S.M., Paling C.A., et al. Development of a paw paw herbal shampoo for the removal of head lice. Phytomedicine. 9:2002;743-748
48. Carson C.F., Ashton L., Dry L., et al. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother. 48:2001;450-451
49. Peña E.F. Melaleuca Alternifolia oil: Its use for trichomonal vaginitis and other vaginal infections. Obstet Gynecol. 19:1962;793-795
50. Groppo F.C., Ramacciato J.C., Simoes R.P., et al. Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Int Dent J. 52:2002;433-437
51. Jandourek A., Vaishampayan J.K., Vazquez J.A. Efficacy of Melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS. 12:1998;1033-1037
52. Coldstream Plantation Pty Ltd. Tea tree oil. Available from: http://www.coldstream-plantation.com.au. Accessed January 24, 2003.
53. Council of Standards Australia. Australian Standard AS2782: oil of Melaleuca, terpinen-4-ol type (tea tree oil). August 1997;Council of Standards Australia, Committee CH/21, Essential Oils, Homebush, New South Wales
54. Elsom G.K.F., Hide D. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother. 43:1999;427-428
55. Carson C.F., Hammer K.A., Riley T.V. In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. J Antimicrob Chemother. 37:1996;1177-1178
56. Banes-Marshall L., Cawley P., Phillips C.A. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci. 58:2001;139-145
57. Southwell I., Markham J., Mann C. Significance of cineole for bioactivity and irritancy in tea tree oil. February 1997;Rural Industries Research and Development Corporation, Nedlands, Western Australia
58. Hinou J.B., Harvala C.E., Hinou E.B. Antimicrobial activity screening of 32 common constituents of essential oils. Pharmazie. 44:1989;302-303
59. Christoph F., Kaulfers P.M., Stahl-Biskup E. A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activity of beta-triketones. Planta Med. 66:2000;556-560
60. Knobloch K., Weis N., Weigard H. Mechanism of antimicrobial activity of essential oils. Planta Med. 52:1986;556-560
61. Carson C.F., Mee B.J., Riley T.V. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother. 46:2002;1914-1920
62. Cox S.D., Gustafson J.E., Mann C.M., et al. Tea tree oil causes K+ leakage and inhibits respiration in Escherichia coli. Lett Appl Microbiol. 26:1998;355-358
63. Cox S.D., Mann C.M., Markham J.L., et al. The mode of antimicrobial action on the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol. 88:2000;170-175
64. Budhiraja S.S., Cullum M.E., Sioutis S.S., et al. Biological activity of Melaleuca alternifolia (tea tree) oil component, terpinen-4-ol, in human myelocytic cell line HL-60. J Manipulative Physiolog Therap. 22:1999;447-453
65. Finlay-Jones J., Hart P., Riley T., et al. Anti-inflammatory activity of tea tree oil. 2001;Rural Industries Research and Development Corporation, Nedlands, Western Australia
66. Hart P.H., Brand C., Carson C.F., et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil) suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 49:2000;619-626
67. Brand C., Grimbaldeston M.A., Gamble J.R., et al. Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm Res. 51:2002;236-244
68. Brand C., Townley S.L., Finlay-Jones J.J., et al. Tea tree oil reduces histamine-induced oedema in murine ears. Inflamm Res. 51:2002;283-289
69. Brand C., Ferrante A., Prager R.G., et al. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res. 50:2001;213-219
70. Koh K.J., Pearce A.L., Marshman G., et al. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol. 147:2002;1212-1217
71. Gustafson J.E., Cox S.D., Liew Y.C., et al. The bacterial multiple antibiotic resistant (Mar) phenotype leads to increased tolerance to tea tree oil. Pathology. 33:2001;211-215
72. Aono R., Kobayashi H. Cell surface properties of organic solvent-tolerant mutants of Escherichia coli K-12. Appl Environ Microbiol. 63:1997;3637-3642
73. Okusu H., Ma D., Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J Bacteriol. 178:1996;306-308
74. White D.G., Goldman J.D., Demple B., et al. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol. 179:1997;6122-6126
75. Mann C.M., Cox S.D., Markham J.L. The outer membrane of Pseudomonas aeruginosa NCYC 6749 contributes to its tolerance of the essential oil of Melaleuca alternifolia (tea tree oil). Lett Appl Microbiol. 30:2000;294-297
76. Pattnaik S., Rath C., Subramanyam V.R. Characterization of resistance to essential oils in a strain of Pseudomonas aeruginosa (VR-6). Microbios. 81:1995;29-31
77. Ford R.A. Fragrance raw materials monographs (tea tree oil). Food Chem Toxicol. 26:1988;407
78. Buckle J. Clinical aromatherapy in nursing. 1998;Arnold, London
79. Hayes A.J., Leach D.N., Markham J.L. In vitro cytotoxicity of Australian tea tree oil using human cell lines. J Essential Oil Res. 9:1997;575-582
80. de Groot A.C., Weyland J.W. Systemic contact dermatitis from tea tree oil. Contact Dermatitis. 27:1992;279-280
81. Selvaag E., Holm J.-O., Thune P. Allergic contact dermatitis in an aroma therapist with multiple sensitizations to essential oils. Contact Dermatitis. 33:1995;354-355
82. Selvaag E., Eriksen B., Thune P. Contact allergy to tea tree oil and cross-sensitization to colophony. Contact Dermatitis. 31:1994;124-125
83. Villan D., Knight M.J., Hansen S.R., et al. Toxicity of Melaleuca oil and related essential oils applied topically on dogs and cats. Vet Hum Toxicol. 36:1994;139-142
84. Apted J.H. Contact dermatitis associated with the use of tea tree oil. Australas J Dermatol. 32:1991;177
85. Varma S., Blackford S., Statham B.N., et al. Combined contact allergy to tea tree oil and lavender oil complicating chronic vulvovaginitis. Contact Dermatitis. 42:2000;309-310
86. Bhushan M., Beck M.H. Allergic contact dermatitis from tea tree oil in a wart paint. Contact Dermatitis. 36:1997;117-118
87. Del Beccaro M.A. Melaleuca oil poisoning in a 17-month old. Vet Hum Toxicol. 37:1995;557-558
88. Jacobs M.R., Hornfeldt M.S. Melaleuca oil poisoning. Clin Toxicol. 32:1994;461-464
89. Elliot C. Tea tree oil poisoning. Med J Aust. 159:1993;830-831
90. Seawright A. Comment: Tea tree oil poisoning. Med J Aust. 159:1993;831
91. Zhang S.Y., Robertson D. A study of tea tree oil ototoxicity. Audiol Neuro-Otol. 5:2000;64-68
92. Vilaplana J., Romaguera C. Allergic contact dermatitis due to eucalyptol in an anti-inflammatory cream. Contact Dermatitis. 43:2000;118
93. Knight T.E., Hausen B.M. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol. 30:1994;423-427
94. Perret C.M., Evans A.V., Russell-Jones R. Tea tree oil dermatitis associated with linear IgA disease. Clin Exp Dermatol. 28:2002;167-170
95. Dharmagunawardena B., Takwale A., Sanders K.J., et al. Gas chromatography: an investigative tool in multiple allergies to essential oils. Contact Dermatitis. 47:2002;288-292
96. Brenan J.A., Dennerstein G.J., Sfameni S.F., et al. Evaluation of patch testing in patients with chronic vulvar symptoms. Australas J Dermatol. 37:1996;40-43
97. Rubel D.M., Freeman S., Southwell I.A. Tea tree oil allergy: what is the offending agent? Report of three cases of tea tree oil allergy and review of the literature. Australas J Dermatol. 39:1998;244-247
98. Southwell I., Freeman S., Rubel D. Skin irritancy of tea tree oil. J Essential Oils Res. 9:1997;47-52
99. Fritz T.M., Burg G., Krasovec M. Allergic contact dermatitis to cosmetics containing Melaleuca alternifolia (tea tree oil). Ann Dermatol Venereol. 128:2001;123-126
100. Sherry E, Warnke PH. Alternative for MRSA and tuberculosis (TB): eucalyptus and tea-tree oils as new topical antibacterials (poster). Paper presented at annual meetings of American Academy of Orthopaedic Surgeons, Dallas (TX), February 13-17, 2002.
101. Soderberg T.A., Johansson A., Gref R. Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology. 107:1996;99-109
102. Hausen B.M., Reichling J., Harkenthal M. Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am J Contact Dermatol. 10:1999;68-77
103. Greig J., Thoo S.L., Carson C.F., et al. Allergic contact dermatitis following use of a tea tree oil hand-wash not due to tea tree oil. Contact Dermatitis. 41:1999;354-355
104. Bartek M.J., LaBudde J.A., Maibach H.I. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J Invest Dermatol. 58:1972;114-123
105. Ceschel G.C., Maffei P., Moretti M.D.L., et al. In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei & Picci essential oil from topical formulations. Int J Pharm. 195:2000;171-177
106. Sherry E., Boeck H., Warnke P. Topical application of a new formulation of eucalyptus oil phytochemical clears methicillin-resistant Staphylococcus aureus infection. Am J Infect Control. 29:2001;346
107. Sherry E., Sivananthan S., Warnke P.H., Eslick G.D. Topical phytochemicals used to salvage the gangrenous lower limbs of type 1 diabetic patients. Diabetes Res Clin Pract. 62:2003;65-66
108. Kerr J. Research project: using essential oils in wound care for the elderly. Aromatherapy Today. 23:2002;14-19
109. Hartman D., Coetzee J.C. Two U.S. practitioners' experience of using essential oils for wound care. J Wound Care. 11:2002;317-320
110. Martin K., Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 51:2003;241-246
111. Caelli M., Porteous J., Carson C.F., et al. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect. 46:2000;236-237
112. Schuster B.G. Demonstrating the validity of natural products as anti-infective drugs. J Alternative Complementary Med. 7:(Suppl 1):2001;73-82